|
ZNF737 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.461570E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.393400E-01 |
| Normal-vs-Stage2 |
6.883200E-01 |
| Normal-vs-Stage3 |
3.169800E-02 |
| Normal-vs-Stage4 |
1.484120E-03 |
| Stage1-vs-Stage2 |
7.604800E-01 |
| Stage1-vs-Stage3 |
1.914380E-02 |
| Stage1-vs-Stage4 |
3.624300E-04 |
| Stage2-vs-Stage3 |
2.567000E-01 |
| Stage2-vs-Stage4 |
9.504100E-02 |
| Stage3-vs-Stage4 |
3.621600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.072800E-01 |
| Normal-vs-AfricanAmerican |
2.946000E-02 |
| Normal-vs-Asian |
5.774400E-01 |
| Caucasian-vs-AfricanAmerican |
1.659600E-01 |
| Caucasian-vs-Asian |
9.386800E-01 |
| AfricanAmerican-vs-Asian |
6.172800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.499900E-02 |
| Normal-vs-Female |
8.832800E-01 |
| Male-vs-Female |
5.697700E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.760440E-02 |
| Normal-vs-Age(41-60Yrs) |
4.428800E-01 |
| Normal-vs-Age(61-80Yrs) |
1.323630E-01 |
| Normal-vs-Age(81-100Yrs) |
1.766370E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.114000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.583500E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.781000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.032800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.757000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.868200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.624550E-01 |
| Normal-vs-Grade 2 |
5.435000E-01 |
| Normal-vs-Grade 3 |
1.359540E-02 |
| Normal-vs-Grade 4 |
2.46559999994567E-06 |
| Grade 1-vs-Grade 2 |
2.194000E-01 |
| Grade 1-vs-Grade 3 |
3.527800E-02 |
| Grade 1-vs-Grade 4 |
5.764000E-03 |
| Grade 2-vs-Grade 3 |
4.575800E-04 |
| Grade 2-vs-Grade 4 |
1.77840000503693E-08 |
| Grade 3-vs-Grade 4 |
3.401500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.969610E-01 |
| Normal-vs-ccB subtype |
5.700800E-03 |
| ccA subtype-vs-ccB subtype |
1.65747999999466E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.804200E-01 |
| Normal-vs-N1 |
1.240700E-03 |
| N0-vs-N1 |
4.381700E-04 |
|
|
